Vegf incorporated into calcium phosphate ceramics promotes vascularisation and bone formation in vivo

European Cells and Materials

Volumn 19, Issue , 2010, Pages 30-40

  Wernike, E ^a   Montjovent, M O ^a,b   Liu, Y ^a,c   Wismeijer, D ^c   Hunziker, E B ^a   Siebenrock, K A ^b   Hofstetter, W ^a   Klenke, F M ^a,b  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Angiogenesis; Biomaterials; Bone formation; Calcium phosphates; Drug delivery; Tissue engineering

Indexed keywords

BIOMATERIAL; CALCIUM PHOSPHATE; CALCIUM PHOSPHATE CERAMIC; RECOMBINANT VASCULOTROPIN; VASCULOTROPIN;

ADSORPTION; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BAGG ALBINO MOUSE; BONE REGENERATION; CONTROLLED STUDY; HYPOTHESIS; IN VITRO STUDY; IN VIVO STUDY; MALE; MICROSCOPY; MORPHOMETRICS; MOUSE; NONHUMAN; OSSIFICATION; OSTEOCLAST; PRECIPITATION; PROTEIN SECRETION; SKULL DEFECT; VASCULARIZATION;

EID: 77950654906     PISSN: 14732262     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Baddeley AJ, Gundersen HJ, Cruz-Orive LM (1986) Estimation of surface area from vertical sections. J Microsc 142: 259-276.
2. Bouletreau PJ, Warren SM, Spector JA, Peled ZM, Gerrets RP, Greenwald JA, Longaker MT (2002) Hypoxia and VEGF up-regulate BMP-2 mRNA and protein expression in microvascular endothelial cells: implications for fracture healing. Plast Reconstr Surg 109: 2384-2397.
3. Chang BS, Lee CK, Hong KS, Youn HJ, Ryu HS, Chung SS, Park KW (2000) Osteoconduction at porous hydroxyapatite with various pore configurations. Biomaterials 21: 1291-1298.
4. Clarke SA, Hoskins NL, Jordan GR, Marsh DR (2007) Healing of an ulnar defect using a proprietary TCP bone graft substitute, JAX, in association with autologous osteogenic cells and growth factors. Bone 40: 939-947.
5. Clarkin CE, Emery RJ, Pitsillides AA, Wheeler-Jones CP (2008) Evaluation of VEGF-mediated signaling in primary human cells reveals a paracrine action for VEGF in osteoblast-mediated crosstalk to endothelial cells. J Cell Physiol 214: 537-544.
6. Deckers MM, van Bezooijen RL, van der HG, Hoogendam J, van der BC, Papapoulos SE, Lowik CW (2002) Bone morphogenetic proteins stimulate angiogenesis through osteoblast-derived vascular endothelial growth factor A. Endocrinology 143: 1545-1553.
7. Drake CJ, Little CD (1995) Exogenous vascular endothelial growth factor induces malformed and hyperfused vessels during embryonic neovascularization. Proc Natl Acad Sci U S A 92: 7657-7661.
8. Ennett AB, Kaigler D, Mooney DJ (2006) Temporally regulated delivery of VEGF in vitro and in vivo. J Biomed Mater Res A 79: 176-184.
9. Finkemeier CG (2002) Bone-grafting and bone-graft substitutes. J Bone Joint Surg Am 84-A: 454-464.
10. Gao H, Wang YN, Fan YG, Ma JB (2007) Conjugates of poly(DL-lactide-co-glycolide) on amino cyclodextrins and their nanoparticles as protein delivery system. J Biomed Mater Res A 80: 111-122.
11. Geiger F, Bertram H, Berger I, Lorenz H, Wall O, Eckhardt C, Simank HG, Richter W (2005) Vascular endothelial growth factor gene-activated matrix (VEGF165-GAM) enhances osteogenesis and angiogenesis in large segmental bone defects. J Bone Miner Res 20: 2028-2035.
12. Geiger F, Lorenz H, Xu W, Szalay K, Kasten P, Claes L, Augat P, Richter W (2007) VEGF producing bone marrow stromal cells (BMSC) enhance vascularization and resorption of a natural coral bone substitute. Bone 41: 516-522.
13. Gerber HP, Vu TH, Ryan AM, Kowalski J, Werb Z, Ferrara N (1999) VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med 5: 623-628.
14. Gerlowski LE, Jain RK (1986) Microvascular permeability of normal and neoplastic tissues. Microvasc Res 31: 288-305.
15. Grellier M, Ferreira-Tojais N, Bourget C, Bareille R, Guillemot F, Amedee J (2009) Role of vascular endothelial growth factor in the communication between human osteoprogenitors and endothelial cells. J Cell Biochem 106: 390-398.
16. Guenther HL, Fleisch H, Sorgente N (1986) Endothelial cells in culture synthesize a potent bone cell active mitogen. Endocrinology 119: 193-201.
17. Gundersen HJ, Jensen EB (1987) The efficiency of systematic sampling in stereology and its prediction. J Microsc 147: 229-263.
18. Harper J, Klagsbrun M (1999) Cartilage to bone -angiogenesis leads the way. Nat Med 5: 617-618.
19. Hoffmann JN, Vollmar B, Laschke MW, Inthorn D, Fertmann J, Schildberg FW, Menger MD (2004) Microhemodynamic and cellular mechanisms of activated protein C action during endotoxemia. Crit Care Med 32: 1011-1017.
20. Horowitz JR, Rivard A, van der Zee R, Hariawala M, Sheriff DD, Esakof DD, Chaudhry GM, Symes JF, Isner JM (1997) Vascular endothelial growth factor/vascular permeability factor produces nitric oxide-dependent hypotension. Evidence for a maintenance role in quiescent adult endothelium. Arterioscler Thromb Vasc Biol 17: 2793-2800.
21. Huang YC, Kaigler D, Rice KG, Krebsbach PH, Mooney DJ (2005) Combined angiogenic and osteogenic factor delivery enhances bone marrow stromal cell-driven bone regeneration. J Bone Miner Res 20: 848-857.
22. Kaigler D, Wang Z, Horger K, Mooney DJ, Krebsbach PH (2006) VEGF scaffolds enhance angiogenesis and bone regeneration in irradiated osseous defects. J Bone Miner Res 21: 735-744.
23. Kanczler JM, Oreffo RO (2008) Osteogenesis and angiogenesis: the potential for engineering bone. Eur Cell Mater 15: 100-114.
24. Kempen DH, Lu L, Heijink A, Hefferan TE, Creemers LB, Maran A, Yaszemski MJ, Dhert WJA (2009) Effect of local sequential VEGF and BMP-2 delivery on ectopic and orthotopic bone regeneration. Biomaterials 30: 2816-2825.
25. Kleinheinz J, Stratmann U, Joos U, Wiesmann HP (2005) VEGF-activated angiogenesis during bone regeneration. J Oral Maxillofac Surg 63: 1310-1316.
26. Klenke FM, Liu Y, Yuan H, Hunziker EB, Siebenrock KA, Hofstetter W (2008) Impact of pore size on the vascularization and osseointegration of ceramic bone substitutes in vivo. J Biomed Mater Res A 85: 777-786.
27. Komatsu DE, Hadjiargyrou M (2004) Activation of the transcription factor HIF-1 and its target genes, VEGF, HO-1, iNOS, during fracture repair. Bone 34: 680-688.
28. Lee RJ, Springer ML, Blanco-Bose WE, Shaw R, Ursell PC, Blau HM (2000) VEGF gene delivery to myocardium: deleterious effects of unregulated expression. Circulation 102: 898-901.
29. Leunig M, Yuan F, Menger MD, Boucher Y, Goetz AE, Messmer K, Jain RK (1992) Angiogenesis, microvascular architecture, microhemodynamics, and interstitial fluid pressure during early growth of human adenocarcinoma LS174T in SCID mice. Cancer Res 52: 6553-6560.
30. Liu Y, Layrolle P, de Bruijn J, van Blitterswijk C, de Groot K (2001) Biomimetic coprecipitation of calcium phosphate and bovine serum albumin on titanium alloy. J Biomed Mater Res 57: 327-335.
31. MacNeal WJ (1922) Tetrachrome blood stain: an economical and satisfactory imitation of Leishman's stain. J Am Med Assoc 78: 1122-1123.
32. Mayr-Wohlfart U, Waltenberger J, Hausser H, Kessler S, Gunther KP, Dehio C, Puhl W, Brenner RE (2002) Vascular endothelial growth factor stimulates chemotactic migration of primary human osteoblasts. Bone 30: 472-477.
33. Murphy WL, Simmons CA, Kaigler D, Mooney DJ (2004) Bone regeneration via a mineral substrate and induced angiogenesis. J Dent Res 83: 204-210.
34. Nolte D, Zeintl H, Steinbauer M, Pickelmann S, Messmer K (1995) Functional capillary density: an indicator of tissue perfusion? Int J Microcirc Clin Exp 15: 244-249.
35. Patel ZS, Ueda H, Yamamoto M, Tabata Y, Mikos AG (2008) In vitro and in vivo release of vascular endothelial growth factor from gelatin microparticles and biodegradable composite scaffolds. Pharm Res 25: 2370-2378.
36. Peng H, Wright V, Usas A, Gearhart B, Shen HC, Cummins J, Huard J (2002) Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4. JClinInvest 110: 751-759.
37. Peng H, Usas A, Olshanski A, Ho AM, Gearhart B, Cooper GM, Huard J (2005) VEGF improves, whereas sFlt1 inhibits, BMP2-induced bone formation and bone healing through modulation of angiogenesis. J Bone Miner Res 20: 2017-2027.
38. Penney DP, Powers JP, Frank M, Willis C, Churukian C (2002) Analysis and testing of biological stains - The Biological Stain Commission Procedures. Biotech Histochem 77: 237-275.
39. Rucker M, Laschke MW, Junker D, Carvalho C, Schramm A, Mulhaupt R, Gellrich NC, Menger MD (2006) Angiogenic and inflammatory response to biodegradable scaffolds in dorsal skinfold chambers of mice. Biomaterials 27: 5027-5038.
40. Samee M, Kasugai S, Kondo H, Ohya K, Shimokawa H, Kuroda S (2008) Bone morphogenetic protein-2 (BMP-2) and vascular endothelial growth factor (VEGF) transfection to human periosteal cells enhances osteoblast differentiation and bone formation. J Pharmacol Sci 108: 18-31.
41. Street J, Bao M, deGuzman L, Bunting S, Peale FV, Jr., Ferrara N, Steinmetz H, Hoeffel J, Cleland JL, Daugherty A, van Bruggen N, Redmond HP, Carano RA, Filvaroff EH (2002) Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc Natl Acad Sci USA 99: 9656-9661.
42. Uchida S, Sakai A, Kudo H, Otomo H, Watanuki M, Tanaka M, Nagashima M, Nakamura T (2003) Vascular endothelial growth factor is expressed along with its receptors during the healing process of bone and bone marrow after drill-hole injury in rats. Bone 32: 491-501.
43. Vajanto I, Rissanen TT, Rutanen J, Hiltunen MO, Tuomisto TT, Arve K, Narvanen O, Manninen H, Rasanen H, Hippelainen M, Alhava E, Yla-Herttuala S (2002) Evaluation of angiogenesis and side effects in ischemic rabbit hindlimbs after intramuscular injection of adenoviral vectors encoding VEGF and LacZ. J Gene Med 4: 371-380.
44. Wernike E, Hofstetter W, Liu Y, Wu G, Sebald HJ, Wismeijer D, Hunziker EB, Siebenrock KA, Klenke FM (2010) Long-term cell-mediated protein release from calcium phosphate ceramics. J Biomed Mater Res A 92: 463-474.
45. Zisch AH, Lutolf MP, Ehrbar M, Raeber GP, Rizzi SC, Davies N, Schmokel H, Bezuidenhout D, Djonov V, Zilla P, Hubbell JA (2003) Cell-demanded release of VEGF from synthetic, biointeractive cell ingrowth matrices for vascularized tissue growth. FASEB J 17: 2260-2262.